来自美国国立卫生研究院等机构的科学家们通过进行一项为期11年的研究，进一步描述了特发性CD4淋巴细胞减少症（ICL，idiopathic CD4 lymphocytopenia）的特征，其是一种罕见的 近日，一篇发表在国际杂志New England Journal of Medicine上题为“Reappraisal of Idiopathic CD4 ...

We retrospectively analyzed 56 consecutive patients with relapsed or refractory indolent B-NHL and MCL who received bendamustine (Treakisym) with or without rituximab at our institution between 2011 ...

本研究针对抗CD20疗法（如ocrelizumab/OCR和rituximab/RTX）治疗神经炎症性疾病时引发的继发性低丙种球蛋白血症（HGG）和淋巴细胞 ...

Idiopathic CD4 T Lymphocytopenia (ICL) is a rare immunological syndrome defined by persistently low CD4+ T-cell counts, typically below 300 cells/µL, in the absence of human immunodeficiency virus ...

Hyperfractionated radiation therapy with or without concurrent low-dose daily carboplatin/etoposide for stage III non-small-cell lung cancer: a randomized study. Fifteen patients with inoperable stage ...

We report the case of a 54-year-old woman with multiple sclerosis who was treated with delayed-release dimethyl fumarate (DMF; Tecfidera, Biogen Idec) and who died on October 13, 2014, from ...

Fumaric acid esters, which are prescribed for the treatment of psoriasis and multiple sclerosis, are considered to have a favorable risk profile. However, treatment-related progressive multifocal ...

Inoculation of humans with wild or attenuated myxoviruses induces transient alterations in lymphocyte count and function. The effects of A/New Jersey/76 virus, a killed influenza virus vaccine, on ...

National Institutes of Health researchers shared new details about idiopathic CD4 lymphocytopenia (ICL), a rare immune deficiency that leaves people vulnerable to infectious diseases, autoimmune ...

ROCKVILLE, Md.--(BUSINESS WIRE)--NeoImmuneTech, Inc. (NIT), a T cell-focused therapeutics company, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation ...

Researchers at the University of Rochester Medical Center have conducted a study suggesting that having a low white blood cell count (lymphocytopenia) prior to exposure to severe acute respiratory ...

A new study suggests the need for caution in switching from fingolimod to a B cell–depleting anti-CD20 treatment such as ocrelizumab for patients with multiple sclerosis (MS). Italian researchers ...